JRJeremy B. Rhoten

Jeremy B. Rhoten

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jeremy B. Rhoten has a total of 121 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Association of Multimodal Collateral Profiles with Outcomes After Large Core Thrombectomy

    by Rahul R. Karamchandani, Liang Wang, Gary Defilipp, Jonathan D. Clemente, Milan T. Quinn, Jeremy B. Rhoten, Dale Strong, Andrew W. Asimos

    Background/Objectives: Cerebral collateral circulation markers in large core thrombectomy and their impact on functional outcomes have not been extensively reported. Methods: We retrospectively analyzed health system medical records of large core (Alberta Stroke Program Early Computed Tomography Score p = 0.889). No significant difference was observed between CCC± and CCC− patients (OR 0.869, 95% CI 0.293–2.577, p = 0.800). Glucose was the only factor independently associated with 90-day outcomes (OR 0.742, 95% CI 0.602–0.915, p = 0.005). Conclusions: No independent association was detected between favorable or mixed cerebral collateral circulation and 90-day mRS 0–3 after large core thrombectomy, though the study was underpowered for the CCC+ comparison. Presenting glucose may inform the likelihood of achieving independent ambulatory status at 90 days.

  • Open Access

    Early Reperfusion in Basilar Artery Occlusion Stroke Managed With Tenecteplase Versus Alteplase Before Endovascular Treatment

    by Dylan N. Wolman, Rahul R. Karamchandani, Kwadwo Darko, Tyler M. Bielinski, Nitin Goyal, Jeremy B. Rhoten, Mahesh V. Jayaraman, Christian T. Sidebottom, Bradley A. Gross, Alhamza R. Al-Bayati, et al.

    BACKGROUND: Timely reperfusion is a critical determinant of favorable outcomes in basilar artery occlusion (BAO) stroke. We aimed to examine whether the choice of thrombolytic agent predicts early reperfusion (ER) in BAO stroke managed with tenecteplase versus alteplase before endovascular treatment. METHODS: This was a retrospective, multicenter US cohort of consecutive patients with BAO from 14 stroke centers treated with tenecteplase or alteplase within 4.5 hours of last known well before endovascular treatment. The primary end point was ER, defined as angiographic ER (expanded Thrombolysis in Cerebral Infarction grade 2b to 3 on the first diagnostic angiogram), or clinical ER, defined as substantial neurological improvement precluding endovascular treatment and a good functional outcome (modified Rankin Scale score 0–3). RESULTS: Among 163 patients with BAO and a median last known well-to-needle time of 135 minutes (interquartile range, 100–193) and last known well-to-puncture time of 228 minutes (interquartile range, 166–307), ER was observed in 27 (16.6%) patients. Rates of ER were comparable between tenecteplase (14/75, 18.7%) and alteplase (13/88, 14.8%; adjusted odds ratio, 1.082 [95% CI, 0.444–2.631]; P =0.862). In addition, rates of angiographic ER and clinical ER subgroups did not differ between thrombolytic agents. Higher Basilar Artery on Computed Tomography Angiography scores and a nonatherothrombotic cause independently predicted ER. In multivariable analysis, a good functional outcome was associated with younger age, lower stroke burden, and shorter last known well-to-puncture time. CONCLUSIONS: In BAO treated within 4.5 hours of last known well, tenecteplase and alteplase produced comparable early reperfusion rates. Achieving ER did not modify the association between thrombolytic agent and good functional outcome, consistent with rapid thrombectomy in patients with no ER.

  • Open Access

    Quality of life after endovascular thrombectomy: A multicenter, prospective, observational study

    by Rahul R. Karamchandani, Hongmei Yang, Liang Wang, Dale Strong, Jeremy B. Rhoten, Katelynn J. Teli, Anna Maria Helms, Sharon D. Smith, Derica A. Brown, Elizabeth A. Adelman, et al.

  • Open Access

    Association of Computed Tomography Perfusion Parameters with 90-Day Functional Independence After Endovascular Thrombectomy

    by Rahul R. Karamchandani, Liang Wang, Hongmei Yang, Shraddha T. Patel, Karan N. Tarasaria, Dale Strong, Jeremy B. Rhoten, Jonathan D. Clemente, Gary Defilipp, Andrew W. Asimos

    Background/Objectives: Recently, a novel CT perfusion (CTP) parameter, the compensation index (COMPI; ratio of 4 s delayed perfusion to 6 s delayed perfusion), was shown to correlate more strongly with digital subtraction angiographic collaterals than the cerebral blood volume index (CBVI) and hypoperfusion intensity ratio. Methods: We retrospectively analyzed all anterior circulation large vessel occlusion patients treated at multiple thrombectomy centers from January to December 2024 to determine the relationship of COMPI and other CTP parameters with the primary outcome: a 90-day modified Rankin Scale (mRS) score of 0–2. Univariable logistic regression was performed to assess the association between each CTP parameter and the primary outcome in the full cohort and in those achieving endovascular reperfusion (modified treatment in cerebral ischemia 2b-3). Multivariable logistic regression was performed to determine factors independently associated with a 90-day mRS score of 0–2. Results: 323 subjects (median age 69 [57–78] years, median of National Institutes of Health Stroke Scale 15 [10–19.5]) were included, of whom 146/302 (48.3%) were functionally independent at 90 days. The COMPI was not associated with the primary outcome in the univariate analysis. CBVI was the only CTP parameter independently associated with a 90-day mRS score of 0–2 in the full cohort (per 0.1-point increase, odds ratio 1.349, 95% confidence interval 1.099–1.655, p = 0.004) and in those achieving reperfusion. Conclusions: The COMPI was not associated with a 90-day mRS score of 0–2. CBVI was associated with independent neurological function in the full cohort and in reperfused patients, supporting its role as a CTP collateral biomarker and potential risk stratification tool before thrombectomy.

  • Open Access

    Validation of the Charlotte Large Artery Occlusion Endovascular Therapy Outcome Score in a Modern Cohort of Thrombectomy Patients

    by Rahul R. Karamchandani, Liang Wang, Hongmei Yang, Dale Strong, Jeremy B. Rhoten, Jonathan D. Clemente, Gary Defilipp, Elizabeth A. Adelman, William R. Stetler, Andrew W. Asimos

    Background/Objectives: The Charlotte Large artery occlusion Endovascular therapy Outcome Score (CLEOS) predicts neurological outcomes after endovascular thrombectomy (EVT). Given recent expanded indications for EVT, we evaluated CLEOS in a modern cohort of thrombectomy patients. Methods: We retrospectively analyzed consecutive, anterior circulation EVT patients from January to December 2024 at multiple centers. The primary outcome was a 90-day modified Rankin Scale (mRS) score of 4–6. We compared primary outcome rates between the original CLEOS derivation cohort and the validation cohort. The area under the curve (AUC) was calculated for CLEOS and compared to other prognostic scales. Results: In the 347 included patients, the mean age was 67.6 (14.9) years, the median National Institutes of Health Stroke Scale (NIHSS) was 15 (10–20), and 137 (42.2%) had a 90-day mRS score of 4–6. A similar proportion of patients in the validation cohort and the derivation cohort achieved the primary outcome (39% each, p = 0.957). The AUC for CLEOS (0.7416, 95% confidence interval [CI] 0.688–0.795) was superior to that of the Pittsburgh Response to Endovascular therapy (AUC 0.681, 95% CI 0.624–0.738, p < 0.01) and Stroke Prognostication using Age and NIHSS (AUC 0.5982, 95% CI 0.556–0.640, p < 0.01), while a trend was observed compared to Houston Intra-Arterial Therapy-2 (AUC 0.6999, 95% CI 0.644–0.756, p = 0.0657) and Totaled Health Risk in Vascular Events (AUC 0.7046, 95% CI 0.560–0.759, p = 0.07). CLEOS ≥ 700 predicted the primary outcome in 16/19 (84.2%) patients. Conclusions: CLEOS performed well in our modern cohort of thrombectomy patients. Prognostic scales such as CLEOS may be useful in guiding conversations and setting expectations with family members pre- and post-thrombectomy.

  • Association of hypoperfusion intensity ratio and cerebral blood volume Index with good outcome in patients transferred for thrombectomy

    by Andrew W Asimos, Hongmei Yang, Dale Strong, Katelynn J Teli, Jonathan D Clemente, Gary DeFilipp, Joe Bernard, William Stetler, Jonathan M Parish, Andrew Hines, et al.

    Background: Hypoperfusion intensity ratio (HIR) and cerebral blood volume index (CBVI) have been shown to predict clinical outcome, but further validation is needed in patients initially presenting to non-thrombectomy centers. Methods: We conducted a retrospective study of patients with an anterior circulation large vessel occlusion (ACLVO) who underwent computed tomography perfusion (CTP) scanning at a non-thrombectomy center and were transferred for consideration of thrombectomy. We evaluated the association of three measures of collateral status (HIR, CBVI, and a collateral score combining both measures) to 90-day modified Rankin scale (mRS). Results: We identified 497 eligible patients, of whom 93% underwent thrombectomy. After adjusting for covariates, ascending numerical CBVI was associated with 90-day mRS ≤ 2 in both overall patients and the recanalized subgroup ( n = 436). In the recanalized subgroup, 90-day mRS ≤ 2 among patients with CBVI > 0.7 was 56% versus 36% with CBVI ≤ 0.7 [adjusted OR: 1.73 (1.13–2.65), p = 0.012]. Neither HIR thresholds below 0.4, 0.5, and 0.6, nor a good versus poor collateral score, were associated with independent or improved functional outcome,. Conclusion: In this study of ACLVO patients transferred for thrombectomy consideration, ascending numeric CBVI was associated with independent function in both the overall population and the recanalized subgroup, and CBVI > 0.7 was associated with both independent and improved functional outcome in recanalized patients. Among CTP measures of collateral status, CBVI alone may play an important role in stroke prognostication and management for ACLVO patients who initially present to a non-thrombectomy center.


  • Prehospital FAST-ED Score Item Agreement with Corresponding In-Hospital NIHSS Item Scores

    by Mark T. Baumgarten, Rahul R. Karamchandani, Dale E. Strong, Lauren Y. Macko, Jeremy B. Rhoten, Tsai-Wei Wang, Hongmei Yang, Douglas R. Swanson, Andrew W. Asimos

    Emergency medical services (EMS) can shorten time to endovascular treatment by transporting large vessel occlusion (LVO) acute ischemic stroke (AIS) patients directly to thrombectomy centers. The standard prehospital strategy for identifying LVO AIS is performing an LVO screen, such as the Field Assessment Stroke Triage for Emergency Destination (FAST-ED), which our county EMS adopted in 2019. We aimed to assess agreement of the FAST-ED score items performed by paramedics in the field with the corresponding National Institutes of Health Stroke Scale (NIHSS) score items obtained by neurologists for patients discharged with an AIS diagnosis. We conducted a retrospective study utilizing a prospectively maintained registry of "Code Stroke" patients. We identified patients ≥ 18 years old transported to 1 of 4 hospitals in our system with a FAST-ED score documented. We included patients diagnosed with AIS for whom the Code Stroke protocol was activated and NIHSS recorded in the registry. As each patient was assessed by 1 paramedic from an EMS clinician pool and 1 neurologist from a hospital pool, we measured corresponding item score agreement using unweighted Fleiss Kappa for the dichotomized measure of facial palsy and quadratic Fleiss Kappa for the other ordinal measures. From September 2019 to March 2024, we identified 829 patients meeting our inclusion criteria. There was substantial agreement between FAST-ED and NIHSS for arm weakness (Kappa = 0.68, 95% confidence interval (CI) 0.63-0.72) and speech changes defined as dysarthria and/or aphasia (Kappa = 0.61, 95% CI 0.56-0.67). Moderate agreement was found for eye deviation (Kappa = 0.60, 95% CI 0.54-0.66) and speech changes not including dysarthria (Kappa = 0.48, 95% CI 0.43-0.54). There was fair agreement for facial palsy (Kappa = 0.25, 95% CI 0.19-0.32) and denial/neglect (Kappa = 0.33, 95% CI 0.26-0.40). We found a range of agreement for items of FAST-ED prehospital scores to corresponding items of in-hospital NIHSS, including only fair agreement for facial palsy and denial/neglect. Our findings suggest EMS clinicians may benefit from targeted education in assessing denial/neglect and facial palsy, as well as how to score the speech component in cases of isolated dysarthria.

  • Open Access

    Very Early Rehabilitation After Treatment with Intravenous Thrombolysis for Mild Acute Ischemic Stroke

    by Rahul R. Karamchandani, Liang Wang, Dale Strong, Alexis A. Mulvaney, Jonathan D. Clemente, Jeremy B. Rhoten

    Background/Objectives: The optimal timing of rehabilitation after acute ischemic stroke is unclear. We studied neurological outcomes and safety of early mobilization (EM) within 24 h for patients receiving intravenous thrombolysis. Methods: This was a retrospective analysis of patients treated at a single Comprehensive Stroke Center from 6/2020–10/2024 with EM versus usual care. Patients were eligible for EM if they were treated with intravenous thrombolysis and had post-treatment National Institutes of Health Stroke Scale scores ≤ 5, and later, ≤10. Ordinal regression was performed to determine factors associated with a 90-day functional outcome benefit in the full cohort. Propensity scores were calculated for matched sample pairs to determine any shift towards better outcomes with EM. Results: Groups of 165 and 73 patients were treated with EM and usual care, respectively. Treatment with EM was not associated with improved 90-day neurological outcome (odds ratio [OR] for higher mRS 0.746, p = 0.265). The groups also had comparable rates of symptomatic intracranial hemorrhage, length of stay, and discharge disposition. In the propensity score analysis of 73 matched pairs, EM was comparable to usual care with respect to 90-day functional outcome (OR for higher mRS 0.891, p = 0.7). Conclusions: Mobilization within 24 h resulted in comparable rates of 90-day neurological function, symptomatic intracranial hemorrhage, and hospital length of stay in patients with mild ischemic stroke treated with intravenous thrombolysis. Future trials may further investigate the safety and efficacy of EM in alternate and larger patient cohorts.

  • Early recanalization after tenecteplase versus alteplase: Experience in a large stroke network

    by Rahul R. Karamchandani, Andrew W. Asimos, Dale Strong, Jeremy B. Rhoten, Jonathan D. Clemente, Gary Defilipp, Joe D. Bernard, William R. Stetler, Jonathan M. Parish, Andrew U. Hines, et al.


  • Neurological outcomes for patients meeting radiographic criteria for DEFUSE 3 and SELECT2

    by Rahul R Karamchandani, Sagar Satyanarayana, Hongmei Yang, Dale Strong, Jeremy Rhoten, Jonathan Clemente, Gary Defilipp, Nikhil M Patel, Joe Bernard, William Stetler, et al.

    Background The DEFUSE 3 and SELECT2 thrombectomy trials included some patients with similar radiographic profiles, although the rates of good functional outcomes differed widely between the studies. Objective To report neurological outcomes for patients who meet CT and CT perfusion (CTP) inclusion criteria common to both DEFUSE 3 and SELECT2. Methods Retrospective study of thrombectomy patients, presenting between November 2016 and December 2023 to a large health system, with Alberta Stroke Program Early CT score ≥6, core infarction 50–69 mL, mismatch ratio ≥1.8, and mismatch volume ≥15 mL. The primary outcome was 90-day modified Rankin Scale score 0–2. A logistic regression analysis was performed to identify independent predictors of the primary outcome. Results 85 patients, with mean age 64.6 (16.6) years and median National Institutes of Health Stroke Scale score 18 (15–23), were included. Thirty-eight of 85 patients (44.7%) were functionally independent at 90 days. Predictors of functional independence included age (OR=0.943, 95% CI 0.908 to 0.980; P=0.003), initial glucose (OR=0.989, 95% CI 0.978 to 1.000; P=0.044), and time last known well to skin puncture (OR=0.997, 95% CI 0.994 to 1.000; P=0.028). The area under the curve for the multivariable model predicting the primary outcome was 0.82 (95% CI 0.73 to 0.92). Conclusion Nearly half of patients meeting radiographic criteria common to DEFUSE 3 and SELECT2 are functionally independent at 90 days, similar to rates reported for the treated DEFUSE 3 cohort. This might be due to their moderate core volumes and large ischemic penumbra.